FDA-Drug2024-09-11Class II
TIRZEPATIDE 20 mg/2mL (10/mg/mL), Rx Only, 2mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-01
ProRx LLC
Hazard
Lack of Assurance of Sterility
Sold states
Nationwide in the USA
Affected count
1,489 vials
Manufactured in
619 Jeffers Cir, Exton, PA, United States
Products
TIRZEPATIDE 20 mg/2mL (10/mg/mL), Rx Only, 2mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0655-2024Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief